Related Experiment Videos
[Exogenous adenosine as an anti-arrhythmia agent]
J Tebbenjohanns1, D Pfeiffer, B Schumacher
1Medizinische Universitätsklinik und Poliklinik Bonn.
Zeitschrift Fur Kardiologie
|January 1, 1996
Summary
Adenosine effectively treats supraventricular tachycardia by slowing heart rate and AV node conduction. Its dose-dependent effects and short half-life make it a valuable tool for diagnosing and managing various cardiac arrhythmias.
Area of Science:
- Cardiac electrophysiology
- Pharmacology of antiarrhythmic agents
Context:
- Adenosine exhibits significant cardiac electrophysiologic effects, notably slowing sinus node and AV node activity.
- Its primary clinical application is managing paroxysmal supraventricular tachycardia (PSVT) due to reentrant mechanisms involving the AV node.
Purpose:
- To review the electrophysiologic effects of adenosine and its therapeutic applications in managing cardiac arrhythmias.
- To discuss the dose-dependent efficacy and short duration of action of adenosine.
- To explore its utility in differentiating wide QRS tachycardias and identifying accessory pathways.
Summary:
- Adenosine's negative dromotropic action on the AV node is key to its antiarrhythmic use, with efficacy increasing with higher doses (up to 12 mg).
- It aids in diagnosing wide QRS tachycardias and unmasking supraventricular arrhythmias.
- Adenosine can terminate certain ventricular tachycardias and is crucial for localizing accessory pathways for ablation procedures.
Impact:
- Adenosine is a critical, rapidly acting agent for acute arrhythmia management and diagnostic procedures.
- Understanding its electrophysiologic effects enhances therapeutic strategies for complex tachycardias.
- Further research is needed to fully elucidate adenosine's role in atrial electrophysiology and specific reentrant pathways.